Literature DB >> 33578680

Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience.

Vladimir Djordjevic1, Nikica Grubor1,2, Jelena Djokic Kovac3,4, Marjan Micev5, Natasa Milic6,7, Djordje Knezevic1,2, Pavle Gregoric2,8, Zeljko Lausevic2,8, Mirko Kerkez1,2, Srbislav Knezevic1,2, Dejan Radenkovic1,2.   

Abstract

The key to the successful management of pancreatic cystic neoplasm (PCN), among which intraductal papillary mucinous neoplasm (IPMN) is the one with the highest risk of advanced neoplasia in resected patients, is a careful combination of clinical, radiological, and histopathological findings. This study aims to perform the comparison of a preoperative evaluation with pathological reports in IPMN and further, to evaluate and compare the diagnostic performance of European evidence-based guidelines on pancreatic cystic neoplasms (EEBGPCN) and Fukuoka Consensus guidelines (FCG). We analyzed 106 consecutive patients diagnosed with different types of PCN, among whom 68 had IPMN diagnosis, at the Clinical Center of Serbia. All the patients diagnosed with IPMNs were stratified concerning the presence of the absolute and relative indications according to EEBGPCN and high-risk stigmata and worrisome features according to FCG. Final histopathology revealed that IPMNs patients were further divided into malignant (50 patients) and benign (18 patients) groups, according to the pathological findings. The preoperative prediction of malignancy according to EEBGPCN criteria was higher than 70% with high sensitivity of at least one absolute or relative indication for resection. The diagnostic performance of FCG was shown as comparable to EEBGPCN. Nevertheless, the value of false-positive rate for surgical resection showed that in some cases, overtreating patients or treating them too early cannot be prevented. A multidisciplinary approach is essential to adequately select patients for the resection considering at the same time both the risks of surgery and malignancy.

Entities:  

Keywords:  guidelines; intraductal papillary mucinous neoplasms; pancreatic cystic neoplasm; validation

Year:  2021        PMID: 33578680      PMCID: PMC7916322          DOI: 10.3390/jcm10040678

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  30 in total

1.  Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.

Authors:  Hiroyuki Maguchi; Satoshi Tanno; Nobumasa Mizuno; Keiji Hanada; Go Kobayashi; Takashi Hatori; Yoshihiko Sadakari; Taketo Yamaguchi; Kosuke Tobita; Ryuichiro Doi; Akio Yanagisawa; Masao Tanaka
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

2.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.

Authors:  Santhi Swaroop Vege; Barry Ziring; Rajeev Jain; Paul Moayyedi
Journal:  Gastroenterology       Date:  2015-04       Impact factor: 22.682

3.  Environmental cadmium exposure and pancreatic cancer: Evidence from case control, animal and in vitro studies.

Authors:  Vladimir R Djordjevic; David R Wallace; Amie Schweitzer; Novica Boricic; Djordje Knezevic; Slavko Matic; Nikola Grubor; Mirko Kerkez; Dejan Radenkovic; Zorica Bulat; Biljana Antonijevic; Vesna Matovic; Aleksandra Buha
Journal:  Environ Int       Date:  2019-05-08       Impact factor: 9.621

4.  The European evidence-based guidelines on pancreatic cystic neoplasms (PCN) in clinical practice: The development of relative and absolute indications for surgery during prospective IPMN surveillance.

Authors:  Yrjö Vaalavuo; Antti Siiki; Anne Antila; Irina Rinta-Kiikka; Juhani Sand; Johanna Laukkarinen
Journal:  Pancreatology       Date:  2020-09-06       Impact factor: 3.996

5.  Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.

Authors:  Youngmin Han; Hongeun Lee; Jae Seung Kang; Jae Ri Kim; Hyeong Seok Kim; Jeong Min Lee; Kyoung-Bun Lee; Wooil Kwon; Sun-Whe Kim; Jin-Young Jang
Journal:  Gastroenterology       Date:  2017-10-23       Impact factor: 22.682

6.  IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.

Authors:  Giovanni Marchegiani; Mari Mino-Kenudson; Klaus Sahora; Vicente Morales-Oyarvide; Sarah Thayer; Cristina Ferrone; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-Del Castillo
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

Review 7.  Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.

Authors:  Brian K P Goh; Damien M Y Tan; Mac M F Ho; Tony K H Lim; Alexander Y F Chung; London L P J Ooi
Journal:  J Gastrointest Surg       Date:  2014-03-26       Impact factor: 3.452

Review 8.  Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines.

Authors:  Nadine C M van Huijgevoort; Marco Del Chiaro; Christopher L Wolfgang; Jeanin E van Hooft; Marc G Besselink
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-09-16       Impact factor: 46.802

9.  Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer.

Authors:  Woohyung Lee; Yejong Park; Jae Woo Kwon; Eunsung Jun; Ki Byung Song; Jae Hoon Lee; Dae Wook Hwang; Changhoon Yoo; Kyu-Pyo Kim; Jae Ho Jeong; Heung-Moon Chang; Baek-Yeol Ryoo; Seo Young Park; Song Cheol Kim
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

Review 10.  Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas.

Authors:  M Heckler; L Brieger; U Heger; T Pausch; C Tjaden; J Kaiser; M Tanaka; T Hackert; C W Michalski
Journal:  BJS Open       Date:  2018-02-05
View more
  1 in total

1.  MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm.

Authors:  Tingting Lin; Xin Chen; Jingjing Liu; Yingying Cao; Wenjing Cui; Zhongqiu Wang; Cheng Wang; Xiao Chen
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.